Free Trial
→ Drop these 5 stocks before the market opens tomorrow! (From Weiss Ratings) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
GRAIL, Inc. stock logo
GRAL
GRAIL
$115.89
-4.5%		$121.46
$41.50
▼
$166.48
$5.46B2.86936,290 shs360,786 shs
Insulet Corporation stock logo
PODD
Insulet
$152.48
+2.1%		$142.14
$126.40
▼
$354.88
$10.36B1.061.35 million shs1.59 million shs
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$91.38
-0.7%		$80.28
$60.10
▼
$156.00
$3.20B2.141.25 million shs840,434 shs
10 Stocks Powering The Next AI Boom Cover
10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
GRAIL, Inc. stock logo
GRAL
GRAIL
-4.50%-4.57%-17.04%+70.75%+36.71%
Insulet Corporation stock logo
PODD
Insulet
+2.14%+4.07%+13.85%+6.38%-54.73%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
-0.67%+3.56%+21.00%+3.16%-23.33%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
GRAIL, Inc. stock logo
GRAL
GRAIL
$115.89
-4.5%		$121.46
$41.50
▼
$166.48
$5.46B2.86936,290 shs360,786 shs
Insulet Corporation stock logo
PODD
Insulet
$152.48
+2.1%		$142.14
$126.40
▼
$354.88
$10.36B1.061.35 million shs1.59 million shs
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$91.38
-0.7%		$80.28
$60.10
▼
$156.00
$3.20B2.141.25 million shs840,434 shs
10 Stocks Powering The Next AI Boom Cover
10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
GRAIL, Inc. stock logo
GRAL
GRAIL
-4.50%-4.57%-17.04%+70.75%+36.71%
Insulet Corporation stock logo
PODD
Insulet
+2.14%+4.07%+13.85%+6.38%-54.73%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
-0.67%+3.56%+21.00%+3.16%-23.33%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
GRAIL, Inc. stock logo
GRAL
GRAIL
2.33
Hold$128.8011.14% Upside
Insulet Corporation stock logo
PODD
Insulet
2.44
Hold$185.6721.76% Upside
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
2.42
Hold$113.3023.99% Upside

Current Analyst Ratings Breakdown

Latest GRAL, TMDX, and PODD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/10/2026
GRAIL, Inc. stock logo
GRAL
GRAIL
Piper Sandler logo
Piper Sandler
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetNeutral$74.00 ➝ $130.00
11/9/2026
Insulet Corporation stock logo
PODD
Insulet
Truist Financial Corporation logo
Truist Financial
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingHold$153.00 ➝ $160.00
11/9/2026
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetNeutral$77.00 ➝ $88.00
11/6/2026
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Canaccord Genuity Group Inc. logo
Canaccord Genuity Group
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetBuy$95.00 ➝ $120.00
11/6/2026
Insulet Corporation stock logo
PODD
Insulet
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetEqual Weight$150.00 ➝ $165.00
11/6/2026
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
JPMorgan Chase & Co. logo
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetNeutral$73.00 ➝ $85.00
11/6/2026
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Needham & Company LLC logo
Needham & Company LLC
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetBuy$106.00 ➝ $110.00
11/5/2026
GRAIL, Inc. stock logo
GRAL
GRAIL
Royal Bank Of Canada logo
Royal Bank Of Canada
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetSector Perform$84.00 ➝ $100.00
11/5/2026
Insulet Corporation stock logo
PODD
Insulet
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetNeutral$150.00 ➝ $171.00
11/5/2026
Insulet Corporation stock logo
PODD
Insulet
JPMorgan Chase & Co. logo
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetNeutral$152.00 ➝ $170.00
11/5/2026
Insulet Corporation stock logo
PODD
Insulet
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetNeutral$150.00 ➝ $170.00
(Data available from 11/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
GRAIL, Inc. stock logo
GRAL
GRAIL
$147.17M35.40N/AN/A$54.57 per share2.12
Insulet Corporation stock logo
PODD
Insulet
$2.71B3.91$6.46 per share23.61$22.76 per share6.70
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$605.49M5.24$3.90 per share23.43$15.85 per share5.77
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
GRAIL, Inc. stock logo
GRAL
GRAIL
-$408.35M-$9.50N/AN/AN/A-243.80%-16.13%-14.38%N/A
Insulet Corporation stock logo
PODD
Insulet
$247.10M$6.1424.8319.011.1413.44%31.76%14.48%N/A
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$190.29M$3.6924.7637.451.7219.85%13.30%4.93%N/A

Latest GRAL, TMDX, and PODD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/5/2026Q3 2026
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$0.2976$0.51+$0.2124$0.46$178.06 million$203.01 million
11/4/2026Q3 2026
GRAIL, Inc. stock logo
GRAL
GRAIL
-$2.45-$2.21+$0.24-$2.21$44.21 million$37.54 million
11/4/2026Q3 2026
Insulet Corporation stock logo
PODD
Insulet
$1.59$1.99+$0.40$2.03$832.63 million$842.00 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
GRAIL, Inc. stock logo
GRAL
GRAIL
N/AN/AN/AN/AN/A
Insulet Corporation stock logo
PODD
Insulet
N/AN/AN/AN/AN/A
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
GRAIL, Inc. stock logo
GRAL
GRAIL
N/A
8.93
8.93
Insulet Corporation stock logo
PODD
Insulet
0.60
2.51
1.83
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
1.46
4.53
4.15

Institutional Ownership

CompanyInstitutional Ownership
GRAIL, Inc. stock logo
GRAL
GRAIL
N/A
Insulet Corporation stock logo
PODD
Insulet
N/A
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
99.67%

Insider Ownership

CompanyInsider Ownership
GRAIL, Inc. stock logo
GRAL
GRAIL
1.83%
Insulet Corporation stock logo
PODD
Insulet
0.36%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
6.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
GRAIL, Inc. stock logo
GRAL
GRAIL
91044.96 million44.14 millionOptionable
Insulet Corporation stock logo
PODD
Insulet
5,40069.37 million69.12 millionOptionable
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
89834.73 million32.34 millionOptionable

Recent News About These Companies

TransMedics Group (NASDAQ:TMDX) Stock Jumps 3.9% - Here's What Happened
November 12 at 12:39 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-transmedics-group-nasdaq-tmdx-stock-jumps-39-heres-what-happened-2026-11-12/
Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
November 12 at 12:23 PM  |  prnewswire.comhttps://www.prnewswire.com/news-releases/did-transmedics-group-inc-insiders-breach-their-fiduciary-duties-to-shareholders-302938131.html
Barclays Reaffirms Their Buy Rating on TransMedics Group (TMDX)
November 11 at 2:47 PM  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/TMDX-Q/pressreleases/8751223/barclays-reaffirms-their-buy-rating-on-transmedics-group-tmdx/
TransMedics: 2027 Setting Up To Be A Pivotal Year
November 11 at 9:48 AM  |  seekingalpha.comhttps://seekingalpha.com/article/4966443-transmedics-2027-setting-up-to-be-a-pivotal-year
UBS Group Forecasts Strong Price Appreciation for TransMedics Group (NASDAQ:TMDX) Stock
November 11 at 1:43 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31190975
TransMedics Group, Inc. 2026 Q3 - Results - Earnings Call Presentation
November 10, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4966188-transmedics-group-inc-2026-q3-results-earnings-call-presentation
TransMedics (TMDX) Just Reclaimed the 200-Day Moving Average
November 10, 2026  |  zacks.comhttps://www.zacks.com/stock/news/3027142/transmedics-tmdx-just-reclaimed-the-200-day-moving-average?cid=cs-stocknewsapi-ft-fundamental_analysis|200_day_moving_average_(yseop)-3027142
TransMedics: Growth Is Accelerating Again And 2027 Looks Promising
November 10, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4965643-transmedics-growth-is-accelerating-again-and-2027-looks-promising
TransMedics: 3 Key Takeaways for Long-Term Investors
November 9, 2026  |  fool.comhttps://www.fool.com/earnings/takeaways/2026/11/09/transmedics-3-key-takeaways-for-long-term-investors/
TransMedics Group (NASDAQ:TMDX) Price Target Raised to $88.00
November 9, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-transmedics-group-nasdaq-tmdx-price-target-raised-to-8800-2026-11-09/
UBS Adjusts TransMedics Group Price Target to $88 From $77, Maintains Neutral Rating
November 9, 2026  |  marketscreener.comM
TransMedics (TMDX) Just Flashed Golden Cross Signal: Do You Buy?
November 9, 2026  |  zacks.comhttps://www.zacks.com/stock/news/3026333/transmedics-tmdx-just-flashed-golden-cross-signal-do-you-buy?cid=cs-stocknewsapi-ft-fundamental_analysis|20_day_moving_average_(yseop)-3026333
TransMedics (TMDX) Recently Broke Out Above the 50-Day Moving Average
November 9, 2026  |  zacks.comhttps://www.zacks.com/stock/news/3026317/transmedics-tmdx-recently-broke-out-above-the-50-day-moving-average?cid=cs-stocknewsapi-ft-fundamental_analysis|50_day_moving_average_(yseop)-3026317
TransMedics Group (NASDAQ:TMDX) Stock Gets Price Target Boost from JPMorgan Chase & Co.
November 9, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-transmedics-group-nasdaq-tmdx-stock-gets-price-target-boost-from-jpmorgan-chase-co-2026-11-09/
TransMedics Group (NASDAQ:TMDX) Price Target Raised to $110.00
November 9, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31187148
IceCure Medical (NASDAQ:ICCM) versus TransMedics Group (NASDAQ:TMDX) Critical Review
November 8, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31186133
TransMedics Group (NASDAQ:TMDX) Shares Gap Up After Strong Earnings
November 8, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31184910
J.P. Morgan Reaffirms Their Hold Rating on TransMedics Group (TMDX)
November 7, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/TMDX/pressreleases/8717448/jp-morgan-reaffirms-their-hold-rating-on-transmedics-group-tmdx/
Some Experts Think TransMedics Group (TMDX) Has a Near-Monopoly on Keeping Donor Organs Alive
November 7, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/experts-think-transmedics-group-tmdx-124206222.html
TransMedics Group (NASDAQ:TMDX) Stock Price Breaks Above 50-Day Moving Average - What's Next?
November 7, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-transmedics-group-nasdaq-tmdx-stock-price-breaks-above-50-day-moving-average-whats-next-2026-11-07/
TransMedics Group (NASDAQ:TMDX) Stock Moved Up to Hold by Wall Street Zen
November 7, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31183384

New MarketBeat Followers Over Time

Media Sentiment Over Time

GRAIL stock logo

GRAIL NASDAQ:GRAL

$115.89 -5.46 (-4.50%)
Closing price 11/13/2026 04:00 PM Eastern
Extended Trading
$116.08 +0.19 (+0.16%)
As of 11/13/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

Insulet stock logo

Insulet NASDAQ:PODD

$152.48 +3.19 (+2.14%)
Closing price 11/13/2026 04:00 PM Eastern
Extended Trading
$152.66 +0.18 (+0.12%)
As of 11/13/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

TransMedics Group stock logo

TransMedics Group NASDAQ:TMDX

$91.38 -0.62 (-0.67%)
Closing price 11/13/2026 04:00 PM Eastern
Extended Trading
$89.50 -1.88 (-2.06%)
As of 11/13/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas